Patent: 6,124,314
✉ Email this page to a colleague
Summary for Patent: 6,124,314
Title: | Osteoporosis compounds |
Abstract: | This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis. |
Inventor(s): | Cameron; Kimberly O. (East Lyme, CT), Lefker; Bruce A. (Gales Ferry, CT), Rosati; Robert L. (Stonington, CT) |
Assignee: | Pfizer Inc. (New York, NY) |
Application Number: | 09/161,797 |
Patent Claims: | see list of patent claims |
Details for Patent 6,124,314
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2017-10-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |